Case File
efta-02556784DOJ Data Set 11OtherEFTA02556784
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02556784
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Friday, July 6, 2012 3:18 AM
To:
Eileen Alexanderson; Melanie Spinella
The IRS has advanced many theories to challenge the gift and estate tax savings occasioned by the use of family entities
and grantor trusts in estate planning. Until recently, most IRS arguments had been rather unsuccessful. However, the IRS
discovered a potent weapon in IRC § 2036(a), which provides that the value of the gross estate includes the value of all
property to the extent the decedent has made a transfer but has retained (i) the possession or enjoyment of, or the right
to income from, the property, or (ii) the right, either alone or in conjunction with any person, to designate the persons
who shall possess or enjoy the property or the income therefrom.
The IRS has been successful in arguing that IRC § 2036(a) requires the inclusion in the decedent's estate of=20 (i)
partnership assets if the decedent continued to derive benefits from the partnership, or of (ii) trust assets, if the
decedent continued to receive distributions, disguised in the form of a note, from assets sold to a "defective" grantor
trust. The IRS has been most successful where=20 the transactions with not imbued with a sufficient quantum of non-tax
objectives, or the economics of the transaction were questionable, most often because the grantor had not left himself
with sufficient assets to live according to his accustomed standard without receiving partnership (or trust) distributions.
The information contained in=this communication is confidential, may be attorney-client privileged, =ay constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to
[email protected], =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all
rights reserved
1
EFTA_R1_01715536
EFTA02556784
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
2556784Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.